Retinopathy of prematurity-incidence today
- PMID: 23719304
- DOI: 10.1016/j.clp.2013.02.001
Retinopathy of prematurity-incidence today
Abstract
Retinopathy of prematurity (ROP) in high-income countries now occurs, mostly in extreme low birth weight infants. In those countries, the incidence of ROP seems to have declined incrementally over the last few decades. But in middle-income countries, high rates of premature birth and increasing resuscitation of premature infants, often with suboptimal standards of care, have resulted in a third epidemic of ROP. Improved maternal and neonatal care, ROP screening guidelines appropriate for middle-income countries, and widespread timely treatment are urgently called for to control this third epidemic.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico.Br J Ophthalmol. 2011 Nov;95(11):1502-5. doi: 10.1136/bjophthalmol-2011-300015. Epub 2011 Jun 7. Br J Ophthalmol. 2011. PMID: 21653214
-
Guideline for the prevention, screening and treatment of retinopathy of prematurity (ROP).S Afr Med J. 2012 Nov 29;103(2):116-25. doi: 10.7196/samj.6305. S Afr Med J. 2012. PMID: 23374306 Review.
-
Retinopathy of prematurity: are we screening too many babies?Eye (Lond). 2002 Sep;16(5):538-42. doi: 10.1038/sj.eye.6700031. Eye (Lond). 2002. PMID: 12194065
-
Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic.Pediatrics. 1990 Sep;86(3):405-12. Pediatrics. 1990. PMID: 2388790
-
[Screening retinopathy of prematurity (ROP)].Cesk Slov Oftalmol. 2014 Apr;70(2):59-60. Cesk Slov Oftalmol. 2014. PMID: 25030314 Review. Czech.
Cited by
-
Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression.Front Pediatr. 2024 Jan 16;12:1322783. doi: 10.3389/fped.2024.1322783. eCollection 2024. Front Pediatr. 2024. PMID: 38292211 Free PMC article. Review.
-
Dysregulation of histone deacetylases in ocular diseases.Arch Pharm Res. 2024 Jan;47(1):20-39. doi: 10.1007/s12272-023-01482-x. Epub 2023 Dec 27. Arch Pharm Res. 2024. PMID: 38151648 Review.
-
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.Int J Mol Sci. 2023 Jul 28;24(15):12090. doi: 10.3390/ijms241512090. Int J Mol Sci. 2023. PMID: 37569464 Free PMC article. Review.
-
The future application of artificial intelligence and telemedicine in the retina: A perspective.Taiwan J Ophthalmol. 2023 Jun 13;13(2):133-141. doi: 10.4103/tjo.TJO-D-23-00028. eCollection 2023 Apr-Jun. Taiwan J Ophthalmol. 2023. PMID: 37484624 Free PMC article. Review.
-
Screening and surveillance for retinopathy of prematurity: A Wilson and Jungner framework approach.J Glob Health. 2023 May 19;13:03028. doi: 10.7189/jogh.13.03028. J Glob Health. 2023. PMID: 37199471 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
